<DOC>
	<DOCNO>NCT02605759</DOCNO>
	<brief_summary>To demonstrate feasibility , safety efficacy CryoBalloon Ablation System treatment esophageal squamous cell dysplasia .</brief_summary>
	<brief_title>Coldplay Cryoablation Dysplastic Squamous Tissue Patients With Esophageal Squamous Cell Dysplasia</brief_title>
	<detailed_description>Multi-center , prospective , single arm , non-randomized study . The study proceed two phase : pilot phase , follow feasibility , safety efficacy phase . In pilot phase , five ( 5 ) patient one ( 1 ) site treat CryoBalloon Ablation System confirm safety feasibility treatment squamous dysplasia . The second phase conduct two ( 2 ) center enroll 50 subject evaluate feasibility , safety efficacy CryoBalloon Ablation System treatment squamous dysplasia .</detailed_description>
	<criteria>At least one unstained lesion ( USL ) esophagus upon high resolution endoscopy Lugol 's stain Flat ( type 0IIb ) appearance USL Total area USLs maximum longitudinal size 6cm cover maximum onehalf circumference esophagus Proven ( histopathological analysis ) mediumgrade highgrade intraepithelial neoplasia ( MGIN HGIN ) least one USL Older 18 year age time consent Operable per institution 's standard Provides write informed consent Ethics Committeeapproved informed consent form Willing able comply study requirement followup Esophageal stenosis stricture prevent advancement therapeutic endoscope within 4cm treatment zone Other USLs contain MGIN , HGIN , ESSC outside designate treatment area Any previous ablative therapy esophagus ( photodynamic therapy , multipolar electrical coagulation , argon plasma coagulation , laser treatment ) radiation therapy esophagus Any previous esophageal surgery ( except antireflux surgery ) Any cancer ( squamous cell nonsquamous cell ) within previous five ( 5 ) year Active inflammation treatment zone due esophageal reflux , confirm endoscopic examination Known history unresolved drug alcohol dependency would limit ability comprehend follow instruction relate informed consent , posttreatment instruction followup guideline Pregnant plan become pregnant study followup period Life expectancy â‰¤2 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>